Medicine & Life Sciences
Adenocarcinoma
29%
Adjuvant Chemotherapy
28%
Alaska Natives
22%
Appointments and Schedules
9%
Bevacizumab
10%
Bortezomib
11%
Capecitabine
12%
Carboplatin
18%
Carcinoma
12%
Cetuximab
22%
Cholangiocarcinoma
19%
Cisplatin
10%
Clinical Trials
16%
Colonic Neoplasms
100%
Colorectal Neoplasms
61%
Confidence Intervals
15%
Disease-Free Survival
33%
Drug Therapy
28%
Esophageal Neoplasms
13%
Esophagogastric Junction
18%
Fluorouracil
55%
gemcitabine
42%
Hepatocellular Carcinoma
15%
Indigenous Peoples
12%
Irinotecan
34%
Klatskin Tumor
18%
Leucovorin
40%
Liver
15%
Liver Neoplasms
9%
Liver Transplantation
11%
Maximum Tolerated Dose
10%
Mutation
12%
Neoadjuvant Therapy
11%
Neoplasm Metastasis
20%
Neoplasms
64%
Neutropenia
10%
Oxaliplatin
65%
Paclitaxel
9%
Pancreatic Neoplasms
18%
Pemetrexed
11%
Pharmacokinetics
11%
Radiotherapy
10%
Randomized Controlled Trials
10%
Recurrence
24%
Stomach
10%
Stomach Neoplasms
14%
Survival
62%
Therapeutics
29%